Biography & Curriculum Vitae

Physician-scientist at the interface of medicine & molecular design.

Dr. Alper Karagöl is a medical doctor (MD, Istanbul University, 1st place in English Medical Program) and MIT Novo Nordisk Postdoctoral Fellow at the MIT Laboratory for Translational Engineering (L4TE).

His research identifies and validates novel drug targets and engineers environment-responsive, peptide-based therapeutic candidates for neurological, hematological, inflammatory, and oncological disease—supported by a portfolio of over 85 publications and manuscripts, featured journal cover art, 3 patent applications, and 15 open-source computational biology tools.

Portrait of Dr. Alper Karagöl
Alper Karagöl, MD
Cambridge, MA · Istanbul
MIT L4TE
Experience

Research & clinical appointments.

OCT 2026 — PRESENT

MIT Novo Nordisk Postdoctoral Fellow · MIT

MIT Laboratory for Translational Engineering (L4TE) · MIT Novo Nordisk AI Fellowship

AI-driven drug discovery, targeted therapeutic design, and next-generation drug delivery platforms.

FEB 2026 — JUN 2026

Medical Student Researcher · King's College London

Clinical Trials Research Team & Medical Elective (Guy's & St Thomas' NHS Trust — Rheumatology)

Big data clinical analysis, Hidden Markov Modeling of epidemiological trajectories, and pharmacoeconomics.

AUG 2022 — SEP 2025

Research Collaborator · Massachusetts Institute of Technology

Laboratory of Molecular Architecture, MIT Media Lab

Alternative mRNA splicing of neurotransmitter transporters, heteromerization and modulator design, MSA-based structure prediction, QTY-code membrane protein engineering, and evolutionary game theory.

JAN 2023 — MAR 2024

Guest Scientist (Sabbatical) & Research Collaborator · UCL / UCLH

Structural Immunology Group, Darwin Building · UCL Medical School & UCLH NHS Foundation Trust

Structural alterations and mutational epistasis in coagulation factors (Factor IX), human genetic variant profiling, and MySQL/web clinical database architecture.

CLINICAL OBSERVERSHIPS

OR Observer · Harvard Medical School / BIDMC

Beth Israel Deaconess Medical Center, Boston

Clinical & surgical observerships spanning Neurosurgery, Interventional Neuroradiology, Head & Neck Oncological Surgery, Otolaryngology, and Stroke Neurology.

2019 — 2026

Doctor of Medicine (MD) · Istanbul University

Istanbul Faculty of Medicine, English Program

Admitted 1st place in cohort (Top 0.015% nationally on YKS, 350 / 2.38M); Dean's Award for Scientific Excellence (2025) and Outstanding Achievement Award in Medical Sciences (2026).

Recognition

Honours, Grants & Awards

  • 2026 · Protein Society Young Investigator Travel Grant
  • 2026 · Outstanding Achievement Award in Medical Sciences — Istanbul University (most Q1 publications)
  • 2025 · Dean's Award for Scientific Excellence — Istanbul University ("New Therapeutic Strategies Targeting Molecular Architecture of Neuronal Transporters")
  • 2024–2025 · Turkish Patent Office PatentleTürkiye Grants (×3) — pH-specific proteins, STING isoform, VAMP2 isoform
  • 2025 · European Academy of Neurology Congress Bursary — Helsinki, Oral Presentations
  • 2024 · KSBNS International Fellowship & TÜBİTAK 2224 Award — Gyeongju, South Korea
  • 2018–2025 · TÜBİTAK 2205 Scientist Support Scholar (7-year national merit scholarship)
  • 2022 · Erich Frank Scholarship — Erich-Frank-Gesellschaft, LMU Munich
  • 2018 · 1st Place Admission Honor — Istanbul Medical Faculty English Program (Top 350 / 2,381,090 on YKS, 0.015%)
  • 2018 · TÜBİTAK 25th National Biology Olympiad — National Bronze Medalist (2nd Marmara Region, 6th in Turkey, 2017)
  • 2017 · BAYER Turkey Science Projects Competition — Certificate of Achievement